The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol

Curr Top Microbiol Immunol. 2002:269:37-55. doi: 10.1007/978-3-642-59421-2_3.

Abstract

Over millions of years of coevolution with their hosts, viruses have developed highly effective strategies to elude the host immune system. The degradation of major histocompatibility complex (MHC) class I heavy chains by human cytomegalovirus (HCMV) is an example of this. Two HCMV proteins, US2 and US11, target newly synthesized MHC class I heavy chains for destruction via a pathway that involves ubiquitin-dependent retrograde transport, or "dislocation", of the heavy chains from the ER to the cytosol, where the proteins are degraded by proteasomes. In this review, US2- and US11-mediated degradation of MHC class I heavy chains is discussed in relation to data concerning the degradation of other ER luminal proteins. A new, unified model for translocon-facilitated dislocation and degradation of MHC class I heavy chains is presented.

Publication types

  • Review

MeSH terms

  • Cytomegalovirus / metabolism*
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / virology*
  • Cytosol / metabolism
  • Endoplasmic Reticulum / metabolism
  • Histocompatibility Antigens Class I / chemistry
  • Histocompatibility Antigens Class I / metabolism*
  • Protein Transport
  • RNA-Binding Proteins / metabolism*
  • Viral Proteins / metabolism*
  • Virus Replication / immunology

Substances

  • Histocompatibility Antigens Class I
  • RNA-Binding Proteins
  • US11 protein, herpesvirus
  • Viral Proteins